MEDIROM Healthcare Technologies Debt to Equity Ratio 2021-2023 | MRM
Current and historical debt to equity ratio values for MEDIROM Healthcare Technologies (MRM) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. MEDIROM Healthcare Technologies debt/equity for the three months ending December 31, 2023 was 0.00.
| MEDIROM Healthcare Technologies Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-12-31 | $0.05B | $0.00B | 30.72 |
| 2023-06-30 | $0.05B | $-0.00B | -15.62 |
| 2022-12-31 | $0.05B | $0.00B | -114.69 |
| 2022-06-30 | $0.05B | $-0.00B | -15.08 |
| 2021-12-31 | $0.05B | $-0.00B | -28.61 |
| 2021-06-30 | $0.05B | $0.00B | 24.24 |
| 2020-12-31 | $0.05B | $0.01B | 10.63 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.014B | $0.049B |
| MEDIROM Healthcare Technologies Inc. is a holistic healthcare company. MEDIROM Healthcare Technologies Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $20.553B | 12.43 |
| Quest Diagnostics (DGX) | United States | $17.434B | 17.67 |
| DaVita (DVA) | United States | $12.330B | 15.95 |
| Encompass Health (EHC) | United States | $10.431B | 24.59 |
| Chemed (CHE) | United States | $8.349B | 25.66 |
| Elanco Animal Health (ELAN) | United States | $7.168B | 17.06 |
| RadNet (RDNT) | United States | $5.281B | 125.26 |
| Option Care Health (OPCH) | United States | $3.902B | 18.49 |
| Amedisys (AMED) | United States | $3.169B | 22.56 |
| LifeStance Health (LFST) | United States | $2.939B | 0.00 |
| Astrana Health (ASTH) | United States | $2.900B | 45.45 |
| Addus HomeCare (ADUS) | United States | $2.341B | 27.46 |
| U.S Physical Therapy (USPH) | United States | $1.436B | 37.81 |
| Pennant (PNTG) | United States | $1.099B | 44.44 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.080B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.227B | 0.00 |
| Daxor (DXR) | United States | $0.045B | 0.00 |
| Psychemedics (PMD) | United States | $0.014B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.013B | 0.00 |
| Ontrak (OTRK) | United States | $0.008B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.001B | 0.00 |